Trial intelligence / Profile preview

Carnipure Tartrate (LCLT) for SARS-CoV-2 Infection

NCT05446961Phase 2Completed

Sponsor
SENAI CIMATEC
Start
Mar 2021
Primary completion
Sep 2021
Countries
1
01

Overview

Phase 2, randomised, double-blind trial (4 arms), sponsored by SENAI CIMATEC. Primary endpoints: Number new SARS-CoV-2 cases at 21 days assessed by RT-PCR and Number of participants with severe COVID pneumonia at 21 days. Started Mar 2021; status: completed.

Beyond the preview

Go deeper on NCT05446961.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05446961.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call